Could eating only during daylight hours improve cancer treatment?
NCT ID NCT06802172
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests whether eating only within an 8-hour window (time-restricted eating) can improve how well cancer treatments work and reduce side effects. It involves 100 Alaska Native and American Indian patients with breast or rectal cancer. Participants will follow the eating plan while receiving standard treatment, and researchers will track tumor response and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- time-restricted eating
- What this could lead to
- If it works, this could offer a simple, sustainable way to boost cancer treatment effectiveness and reduce side effects without strict dieting.
- What could go wrong
- This is an early-stage trial with only 100 participants, so results may not apply broadly. Time-restricted eating may be hard to maintain for some, and its benefits are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alaska Native Medical Center (ANMC)
RECRUITINGAnchorage, Alaska, 99508, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can sound waves replace the scalpel for breast tumors?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- AI platform aims to unlock Real-World cancer data on a massive scale